GLUE
Price:
$5.69
Market Cap:
$349.21M
Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing protein for the treatment of Myc-driven cancers. The company also develops CDK2 to treat ovarian, uterine, and breast cancers; NEK7 for the treatment of inflammatory diseases, such as Crohn's disease, neurodegenerative disease, diabetes, and liver disease; VAV1, a target protein for autoimmune diseases; and BCL11A, a therapeutically-relevant protein in he...[Read more]
Industry
Biotechnology
IPO Date
2021-06-24
Stock Exchange
NASDAQ
Ticker
GLUE
According to Monte Rosa Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.56. This represents a change of 6.95% compared to the average of 6.14 of the last 4 quarters.
The mean historical Current Ratio of Monte Rosa Therapeutics, Inc. over the last ten years is 8.12. The current 6.56 Current Ratio has changed 7.99% with respect to the historical average. Over the past ten years (40 quarters), GLUE's Current Ratio was at its highest in in the June 2021 quarter at 33.20. The Current Ratio was at its lowest in in the March 2020 quarter at 0.
Average
8.12
Median
5.07
Minimum
1.49
Maximum
20.96
Discovering the peaks and valleys of Monte Rosa Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.31%
Maximum Annual Current Ratio = 20.96
Minimum Annual Increase = -53.01%
Minimum Annual Current Ratio = 1.49
Year | Current Ratio | Change |
---|---|---|
2023 | 5.07 | -53.01% |
2022 | 10.79 | -48.51% |
2021 | 20.96 | 1.31% |
2020 | 1.49 | -34.51% |
The current Current Ratio of Monte Rosa Therapeutics, Inc. (GLUE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
12.27
5-year avg
8.12
10-year avg
8.12
Monte Rosa Therapeutics, Inc.’s Current Ratio is less than Nkarta, Inc. (15.91), less than Lyell Immunopharma, Inc. (16.19), less than Generation Bio Co. (7.42), greater than Sana Biotechnology, Inc. (5.20), less than Design Therapeutics, Inc. (41.42), less than Werewolf Therapeutics, Inc. (12.13), less than Ikena Oncology, Inc. (18.22), less than Stoke Therapeutics, Inc. (6.67), greater than Foghorn Therapeutics Inc. (5.69), less than Shattuck Labs, Inc. (7.62), less than Kymera Therapeutics, Inc. (8.45), greater than Nurix Therapeutics, Inc. (5.57), less than Gracell Biotechnologies Inc. (7.73), less than Theseus Pharmaceuticals, Inc. (29.93), less than Erasca, Inc. (16.79),
Company | Current Ratio | Market cap |
---|---|---|
15.91 | $375.37M | |
16.19 | $299.52M | |
7.42 | $145.50M | |
5.20 | $1.12B | |
41.42 | $264.42M | |
12.13 | $88.28M | |
18.22 | $81.56M | |
6.67 | $773.92M | |
5.69 | $416.63M | |
7.62 | $167.05M | |
8.45 | $2.89B | |
5.57 | $1.50B | |
7.73 | $989.87M | |
29.93 | $181.50M | |
16.79 | $807.96M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Monte Rosa Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Monte Rosa Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Monte Rosa Therapeutics, Inc.'s Current Ratio?
How is the Current Ratio calculated for Monte Rosa Therapeutics, Inc. (GLUE)?
What is the highest Current Ratio for Monte Rosa Therapeutics, Inc. (GLUE)?
What is the 3-year average Current Ratio for Monte Rosa Therapeutics, Inc. (GLUE)?
What is the 5-year average Current Ratio for Monte Rosa Therapeutics, Inc. (GLUE)?
How does the current Current Ratio for Monte Rosa Therapeutics, Inc. (GLUE) compare to its historical average?